Check. Change. Control. Cholesterol™

Cholesterol and Cardiovascular Disease

Two doctors and a nurse having a discussion
Cardiovascular Disease remains a leading cause of morbidity and mortality. Currently, an estimated 92.1 million US adults have at least one type of cardiovascular disease which may lead to myocardial infarction (MI), stroke, or death. By 2030, 43.9% of the US adult population is projected to have some type of cardiovascular disease (Benjamin et al., 2017).

Check. Change. Control. Cholesterol™ can make a difference

The use of statin therapy for the prevention of Atherosclerotic Cardiovascular Disease (ASCVD) in many higher risk primary and secondary prevention individuals is supported by an extensive body of evidence. Despite this evidence, many patients remain untreated or undertreated. Since the publication of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, overall statin treatment rates among patients with ASCVD and Diabetes have remained essentially unchanged. The rate of appropriate statin therapy for patients with ASCVD were 48.0% before and 47.3% after 2013 guideline publication. Furthermore, among patients taking statins 1 year after the guideline was issued, 80% of patients with ASCVD and aged <= 75 years were not on guideline-recommended statin therapy (Tran et al., 2016). 

Announcing Check. Change. Control. Cholesterol™ 
The AHA launched Check. Change. Control. Cholesterol to improve the identification and management of cholesterol across the nation. This national initiative aims to reduce the number of Americans who have heart attacks and strokes by urging medical practices, health service organization, and patients to screen and treat this important risk factor. 

Check. Change. Control. Cholesterol supports physicians and care teams by offering access to the latest research, tools, and resources to reach and sustain cholesterol control rates among the adult patient population that they serve. Join us today to help improve the health of the nation. 


Amgen Cardiovascular logo


Amgen is a proud sponsor of the American Heart Association’s Check. Change. Control. Cholesterol.™ Initiative.